Levity

Levity helps leaders cultivate ease with executive programs guided by neurobiology and supported by psychedelic treatment. Nearly half of professionals face mental health symptoms, and mental health stigma causes many related conditions to go untreated. When individuals do access treatment, existing options regularly create undesirable side-effects or fail to improve outcomes. We help executives and founders, professional partners and executive teams achieve their personal and professional goals. Our programming leverages the neurobiological framework and focuses on cultivating awareness of, engaging with and reprogramming outdated ways of being. Qualifying clients can choose to supplement the program with psychedelic treatment. Ketamine is the psychedelic medicine we leverage; it’s safe, legal and therapeutic. A recent study demonstrated that 89% of ketamine recipients report improvements in mental health related symptoms, with 63% reporting a >50% improvement in their symptoms. Ketamine provides these benefits through impacts on the nervous system which support healthy connectivity in the brain. Treatment impacts are extended by leveraging the resulting window of neuroplasticity to evolve outdated ways of being.